Skip to content
10-Q

Quarterly Report

KAIROS PHARMA, LTD. KAPA

0001641172-25-023167

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 20.74M sh
Shares Diluted Q2 2025 · Jun 30, 2025 17.21M sh
Shares Diluted Q2 2025 · Jun 30, 2025 16.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 10.56M sh
Shares Diluted Q2 2025 · Jun 30, 2024 10.56M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.52M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$132K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.03M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.27M
Stockholders Equity Q2 2025 · Jun 30, 2025 $6M
Stockholders Equity Q2 2025 · Mar 31, 2025 $7.13M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.78M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$2.65M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$2.4M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$2.08M
Current Liabilities Q2 2025 · Jun 30, 2025 $676K
Current Liabilities Q2 2025 · Dec 31, 2024 $992K
Current Assets Q2 2025 · Jun 30, 2025 $4.84M
Current Assets Q2 2025 · Dec 31, 2024 $4.17M
Total Assets Q2 2025 · Jun 30, 2025 $6.67M
Total Assets Q2 2025 · Dec 31, 2024 $5.77M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.08
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.05
Eps Basic Q2 2025 · Jun 30, 2025 −$0.08
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2024 −$0.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.05
Sga Expense Q2 2025 · Jun 30, 2025 $960K
Sga Expense Q2 2025 · Jun 30, 2025 $1.73M
Sga Expense Q2 2025 · Jun 30, 2024 $159K
Sga Expense Q2 2025 · Jun 30, 2024 $286K
Rd Expense Q2 2025 · Jun 30, 2025 $496K
Rd Expense Q2 2025 · Jun 30, 2025 $989K
Rd Expense Q2 2025 · Jun 30, 2024 $63K
Rd Expense Q2 2025 · Jun 30, 2024 $228K
Net Income Q2 2025 · Jun 30, 2025 −$1.42M
Net Income Q2 2025 · Jun 30, 2025 −$2.68M
Net Income Q2 2025 · Jun 30, 2024 −$253K
Net Income Q2 2025 · Jun 30, 2024 −$576K
Operating Income Q2 2025 · Jun 30, 2025 −$1.46M
Operating Income Q2 2025 · Jun 30, 2025 −$2.72M
Operating Income Q2 2025 · Jun 30, 2024 −$222K
Operating Income Q2 2025 · Jun 30, 2024 −$514K